These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 33760141)
1. IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells. Gao Y; Wu Y; Zhang N; Yuan H; Wang F; Xu H; Yu J; Ma J; Hou S; Cao X Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760141 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Li S; Chou AP; Chen W; Chen R; Deng Y; Phillips HS; Selfridge J; Zurayk M; Lou JJ; Everson RG; Wu KC; Faull KF; Cloughesy T; Liau LM; Lai A Neuro Oncol; 2013 Jan; 15(1):57-68. PubMed ID: 23115158 [TBL] [Abstract][Full Text] [Related]
3. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling. Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959 [TBL] [Abstract][Full Text] [Related]
4. IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced. Zhu H; Zhang Y; Chen J; Qiu J; Huang K; Wu M; Xia C PLoS One; 2017; 12(1):e0169038. PubMed ID: 28052098 [TBL] [Abstract][Full Text] [Related]
5. The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas. Ren F; Zhao Q; Huang L; Zheng Y; Li L; He Q; Zhang C; Li F; Maimela NR; Sun Z; Jia Q; Ping Y; Zhang Z; Chen X; Yue Y; Liu S; Cao L; Zhang Y Immunol Cell Biol; 2019 May; 97(5):457-469. PubMed ID: 30575118 [TBL] [Abstract][Full Text] [Related]
6. Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence. Zhan D; Ma D; Wei S; Lal B; Fu Y; Eberhart C; Laterra J; Ying M; Li Y; Meeker A; Lopez-Bertoni H; Xia S Mol Cancer Res; 2021 Nov; 19(11):1878-1888. PubMed ID: 34348994 [TBL] [Abstract][Full Text] [Related]
7. IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway. Li K; Ouyang L; He M; Luo M; Cai W; Tu Y; Pi R; Liu A Oncotarget; 2017 Apr; 8(17):28865-28879. PubMed ID: 28427200 [TBL] [Abstract][Full Text] [Related]
8. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma. Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553 [TBL] [Abstract][Full Text] [Related]
9. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362 [TBL] [Abstract][Full Text] [Related]
10. The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells. Xu H; Cao Y; Ruan J; Wang F; He Y; Yang L; Yu T; Du F; Zhang N; Cao X J Neurooncol; 2024 Oct; 170(1):161-171. PubMed ID: 39117967 [TBL] [Abstract][Full Text] [Related]
11. IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status. Kessler J; Güttler A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D Radiother Oncol; 2015 Sep; 116(3):381-7. PubMed ID: 26328938 [TBL] [Abstract][Full Text] [Related]
12. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis. Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic MicroRNA-20a is downregulated by the HIF-1α/c-MYC pathway in IDH1 R132H-mutant glioma. Xu Q; Ahmed AK; Zhu Y; Wang K; Lv S; Li Y; Jiang Y Biochem Biophys Res Commun; 2018 May; 499(4):882-888. PubMed ID: 29625108 [TBL] [Abstract][Full Text] [Related]
14. Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide. Yamashita AS; da Costa Rosa M; Borodovsky A; Festuccia WT; Chan T; Riggins GJ Neuro Oncol; 2019 Feb; 21(2):189-200. PubMed ID: 30184215 [TBL] [Abstract][Full Text] [Related]
15. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1. Ma D; Zhan D; Fu Y; Wei S; Lal B; Wang J; Li Y; Lopez-Bertoni H; Yalcin F; Dzaye O; Eberhart CG; Laterra J; Wilson MA; Ying M; Xia S Cancer Lett; 2021 Oct; 517():35-45. PubMed ID: 34098063 [TBL] [Abstract][Full Text] [Related]
16. IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR. Yin N; Xie T; Zhang H; Chen J; Yu J; Liu F Oncol Lett; 2020 Feb; 19(2):1322-1330. PubMed ID: 31966064 [TBL] [Abstract][Full Text] [Related]
17. R132 mutations in canine isocitrate dehydrogenase 1 (IDH1) lead to functional changes. Kawakami S; Ochiai K; Azakami D; Kato Y; Michishita M; Morimatsu M; Ishiguro-Oonuma T; Onozawa E; Watanabe M; Omi T Vet Res Commun; 2018 Mar; 42(1):49-56. PubMed ID: 29285579 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas. Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678 [TBL] [Abstract][Full Text] [Related]